In short. Transplant medicine for blood and immune disease has named indications, a characterised cell product and a hospital laboratory. A cosmetic clinic has none of it.
Key points
- When transplantation is described, the words attach to an indication, a product specification, a laboratory and a trial programme.
- When a cosmetic preparation is described, the same words attach to a purchase.
- The vocabulary is shared and the structure is not, and the structure is what separates a treatment from a claim.
There is a branch of medicine where stem cell therapy is not a claim but a treatment, and it has been standard for decades. It is worth describing plainly, because the credibility of that branch is what cosmetic marketing borrows, and the two share almost nothing beyond a name.
What the established treatment is
Haematopoietic stem cell transplantation replaces the blood forming system. It is used for a defined set of conditions: certain leukaemias and lymphomas, some inherited blood disorders, aplastic anaemia and selected immune deficiencies. The cells come from bone marrow, from peripheral blood after mobilisation, or from umbilical cord blood, and may come from a donor or from the patient. The patient is prepared with treatment that clears space in the marrow, and the transplant is given into the bloodstream, from which the cells travel to the marrow.
What makes it medicine rather than a product
Four things, each absent from the cosmetic version. There is a named indication, so a physician can say what it is for. There is a defined cell product with a measured dose and a defined characterisation. There is a hospital setting with the laboratory capacity to collect, process, store and release the cells. And there is a body of controlled evidence that a regulator has assessed for that indication. None of this is a matter of opinion, and none of it can be assembled by a clinic that buys a preparation and injects it.
The same words, a different structure
When transplantation is described, the words attach to an indication, a product specification, a laboratory and a trial programme. When a cosmetic preparation is described, the same words attach to a purchase. The vocabulary is shared and the structure is not, and the structure is what separates a treatment from a claim.
Where the borrowing happens
Cosmetic practice borrows three things. It borrows the word, so a preparation inherits the seriousness of a transplant. It borrows the setting, because a treatment offered in a hospital building sounds like hospital medicine. And it borrows the concept of the patient's own cells, which in transplantation is a genuine matching question with a clinical purpose, and in a cosmetic injection is an argument rather than a fact. The borrowing works because most readers know that stem cell therapy is real medicine, which is true, and have not been told which part.
Three differences worth holding on to
- A transplant has a named indication; a cosmetic preparation has a proposed benefit.
- A transplant has a characterised product and a laboratory release process; a cosmetic preparation has a vial.
- A transplant has controlled evidence assessed by a regulator; a cosmetic preparation has a rationale.
What follows on this site is about the second group. The first is described so that it is not confused with the second, and so that statements about the evidence are read as statements about cosmetic preparations rather than about transplantation. Saying that a cosmetic cell injection lacks evidence is not a statement that cells cannot treat disease.
Frequently asked questions
Which conditions is stem cell transplantation established for?
A defined set: certain leukaemias and lymphomas, some inherited blood disorders, aplastic anaemia and selected immune deficiencies. Each is a named indication that a regulator has assessed, which is what allows a physician to state what the treatment is for.
What does a transplant have that a cosmetic cell injection does not?
A named indication, a characterised cell product with a measured dose, a hospital laboratory that collects, processes and releases the cells, and controlled evidence assessed by a regulator. A clinic that buys a preparation and injects it has none of these four.
Does saying cosmetic cell injections lack evidence mean cell therapy does not work?
No. The statement is about cosmetic preparations, not about transplantation. Transplant medicine is established treatment for blood and immune disease, and the two are separated here precisely because conflating them makes both harder to judge.
Risks & Limitations
- Transplantation is established medicine for defined blood and immune conditions; the cosmetic products that borrow the name mostly hold no approval for injection.
- An unapproved cell or tissue preparation usually cannot be identified with certainty and cannot be dissolved, so a result that is unwanted or a lump that forms may not be correctable by an injection.
- Reported harms of unapproved cell and tissue injections include infection at the injection site, collections of pus requiring drainage, prolonged swelling, nodules that do not settle and granuloma formation.
- A preparation made at the point of care has no release testing that a regulator has reviewed, and the cell content of what is injected is often not measured.
- There is no randomised comparison of a stem cell facelift against a placebo or against an established treatment, and no agreed definition of the procedure for a trial to test.
When to Seek Care
- Spreading redness, warmth, fever or discharge from an injection site. Have it assessed by a clinician without delay.
- A firm lump, persistent pain, or skin that is changing colour weeks or months after an injection.
- Any change in vision, or severe pain around the eye, needs emergency care immediately.
- Contact the service that performed the treatment first, and then seek an assessment by somebody who can examine the area.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.